Mrs. Nina Lee Alvan-martinez, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 21510 Tithables Cir, Broadlands, VA 20148 Phone: 703-729-1305 |
Lottie Kohl Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 21000 Education Ct, Broadlands, VA 20148 Phone: 571-252-1014 |
Ms. Frances S Jester, MA, LCSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 21000 Education Ct, Broadlands, VA 20148 Phone: 571-252-1000 |
Julieta Paulina Graves, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 42881 Sandhurst Ct, Broadlands, VA 20148 Phone: 703-939-4732 |
News Archive
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.
Would you choose to receive a small amount of money today or a larger sum next month? We know that it is worth it to wait longer for a larger reward, but sometimes the temptation for the smaller, immediate reward becomes too great and we simply cannot resist it. Selecting the immediate reward is known as "future discounting" and often suggests a lack of self-control.
Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that involves the ineffective production of blood cells, leaving patients anemic and in need of frequent blood transfusions. Because the body has no natural means to reduce iron that accumulates from repeated transfusions, patients' organs can become iron overloaded, leading to heart failure, liver injury, susceptibility to infection, and other complications.
Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.
› Verified 3 days ago